DR. LAL PATHLABS share price has plunged 3% and is presently trading at Rs 3,109.7.
Meanwhile, the BSE HEALTHCARE index is at 40,938.4 (down 0.3%).
Among the top losers in the BSE HEALTHCARE index today are Cadila Healthcare (down 3.0%) and ALEMBIC PHARMA (down 2.4%).
SUVEN PHARMACEUTICALS (up 3.0%) and CAPLIN POINT (up 2.5%) are among the top gainers today.
Over the last one year, DR. LAL PATHLABS has moved up from Rs 2,368.1 to Rs 3,109.7, registering a gain of Rs 741.6 (up 31.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,343.8 to 40,938.4, registering a gain of 44.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 114.1%), GSK Pharma (up 105.9%) and GRANULES INDIA (up 105.5%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,265.6 (down 0.6%).
The top losers among the BSE Sensex today are MUNDRA PORT & SEZ (down 2.6%) and NTPC (down 2.1%). The most traded stocks in the BSE Sensex are Tata Steel and MUNDRA PORT & SEZ.
In the meantime, NSE Nifty is at 24,242.4 (down 0.5%). Adani Enterprises and MUNDRA PORT & SEZ are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,846.5 to 79,265.6, registering a gain of 13,419.1 points (up 20.4%).
DR. LAL PATHLABS net profit grew 28.9% YoY to Rs 1,078 million for the quarter ended June 2024, compared to a profit of Rs 836 million a year ago. Net sales rose 11.3% to Rs 6,019 million during the period as against Rs 5,410 million in April-June 2023.
For the year ended March 2024, DR. LAL PATHLABS reported 50.3% increase in net profit to Rs 3,623 million compared to net profit of Rs 2,411 million during FY23. Revenue of the company grew 10.4% to Rs 22,266 million during FY24.
The current Price to earnings ratio of DR. LAL PATHLABS, based on rolling 12 month earnings, stands at 67.2.
Equitymaster requests your view! Post a comment on "DR. LAL PATHLABS Plunges 3%; BSE HEALTHCARE Index Down 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!